Skip to main navigation Skip to search Skip to main content

Rapid progression to cardiac tamponade in Erdheim–Chester disease despite treatment with interferon alpha

  • Afif Nakhleh
  • , Gleb Slobodin
  • , Nizar Elias
  • , Jacob Bejar
  • , Majed Odeh
  • Bnai-Zion Medical Center

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Erdheim–Chester disease (ECD) is a rare form of non-Langerhans histiocytosis with heterogeneous clinical manifestations. The most common presentation is bone pains typically involving the long bones. Approximately 75% of the patients develop extraskeletal involvement. Cardiac involvement is seen in up to 45% of the patients, and although, pericardial involvement is the most common cardiac pathology of this rare disease, cardiac tamponade due to ECD has been very rarely reported. We describe a case of a patient found to have ECD with multi-organ involvement and small pericardial effusion, which progressed to cardiac tamponade despite treatment with interferon alpha.

Original languageEnglish
Pages (from-to)621-624
Number of pages4
JournalModern Rheumatology
Volume26
Issue number4
DOIs
StatePublished - 3 Jul 2016
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2014 Japan College of Rheumatology.

Keywords

  • Erdheim–Chester disease
  • Interferon alpha
  • Pericarditis tamponade

Fingerprint

Dive into the research topics of 'Rapid progression to cardiac tamponade in Erdheim–Chester disease despite treatment with interferon alpha'. Together they form a unique fingerprint.

Cite this